rss
Br J Ophthalmol 2007;91:1183-1189 doi:10.1136/bjo.2007.114769
  • Extended report
    • Clinical science - Extended reports

Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy

  1. Olcay Tatar1,
  2. Annemarie Adam2,
  3. Kei Shinoda3,
  4. Tillmann Eckert4,
  5. Gábor B Scharioth5,
  6. Micheal Klein6,
  7. Efdal Yoeruek1,
  8. Karl Ulrich Bartz-Schmidt1,
  9. Salvatore Grisanti1
  1. 1
    University Eye Hospital, Centre for Ophthalmology, Eberhard-Karls University, Tuebingen, Germany
  2. 2
    Department of Pathology, Eberhard-Karls University, Tuebingen, Germany
  3. 3
    Laboratory of Visual Physiology, National Institute of Sensory Organs, Tokyo, Japan
  4. 4
    Augenklinik der Staedtischen Kliniken, Frankfurt am Main, Germany
  5. 5
    Augenzentrum Recklinghausen, Germany
  6. 6
    Augenklinik Tausendfensterhaus, Duisburg, Germany
  1. Professor Dr Salvatore Grisanti, University Eye Hospital, Centre for Ophthalmology, Eberhard-Karls University, Tuebingen, Germany, Schleichstrasse 12-15, 72076 Tuebingen, Germany; Salvatore.Grisanti{at}med.uni-tuebingen.de
  • Accepted 8 April 2007
  • Published Online First 2 May 2007

Abstract

Aim: To evaluate expression of proangiogenic matrix metalloproteinases (MMP) 2 and 9 at distinct intervals after verteporfin photodynamic therapy (PDT) in human choroidal neovascular membranes (CNV) secondary to age-related macular degeneration (AMD).

Methods: Retrospective review of an interventional case series of 49 patients who underwent removal of CNV. Twenty-six patients were treated with PDT 3 to 383 days prior to surgery. Twenty-three CNV without previous treatment were used as controls. CNV were stained for CD34, cytokeratin 18, endostatin, MMP-2 and MMP-9 by immunohistochemistry.

Results: CNV without previous therapy disclosed MMP-2, MMP-9 in RPE–Bruch’s membrane, vessels and stroma in different intensities. Three days after PDT, MMP-9 expression was significantly weaker in stroma (p = 0.0019). Endostatin was significantly reduced in vessels (p<0.001). At longer post-PDT intervals, a significant increase of MMP-9 in stroma (p = 0.037) and of endostatin in RPE–Bruch’s membrane (p = 0.02), vessels (p = 0.005) and stroma (p<0.001) were disclosed. No significant changes in MMP-2 expression were detected.

Conclusions: PDT induced an early, temporary decrease in MMP-9 and endostatin expression. At longer intervals, MMP-9 increase is possibly associated with the angiogenic process responsible for recurrence after PDT. MMP-9, however, acts as a double-edged sword by concomitant induction of endostatin, an endogenous inhibitor of angiogenesis.

Footnotes

  • Funding: This work was supported by grants from the Vision 100 Foundation and Jung Foundation.

  • Competing interests: None.

  • Abbreviations:
    AMD

    age-related macular degeneration

    CNV

    choroidal neovascular membranes

    EC

    endothelial cell

    ECM

    extracellular matrix

    MMP

    matrix metalloproteinases

    PDT

    photodynamic therapy

    PEDF

    pigment epithelium-derived factor

    VEGF

    vascular endothelial growth factor

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All Versions of this Article:
    1. bjo.2007.114769v1
    2. 91/9/1183 most recent

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

Register for free content


Free sample
 This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Free archive
The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.